CSIMarket
 

Healthcare Sector

Major Pharmaceutical Preparations Industry Profitability  


Profitability by Company within Major Pharmaceutical Preparations Industry


Company Quarter Gross Margin Net Margin Cash flow Margin ROE
Aadi Bioscience Inc 4 Q 85.35% -257.18% -93.5% -52.53%
Abbvie inc 4 Q 60.11% 5.76% -3.31% 40%
Abcellera Biologics Inc 4 Q - -513.73% -426.03% -12.36%
Abeona Therapeutics Inc 3 Q - -1995.95% -255.14% -201.46%
American Bio Medica Corporation 1 Q 45.12% - 20.73% -
Abbott Laboratories 4 Q 55.51% 15.56% 1.83% 15.53%
Arbutus Biopharma Corp 3 Q - -431.6% -207.51% -7.82%
Abvc Biopharma Inc 3 Q -86.44% -21204.23% - -353.64%
Acadia Pharmaceuticals Inc 3 Q 93.09% -30.79% -5.71% -38.84%
Acer Therapeutics Inc 3 Q 77.46% -3962.25% -257.88% -
Adicet Bio Inc 3 Q - - - -57.66%
Ac Immune Sa 4 Q - -366.41% - -33.76%
Aclaris Therapeutics Inc 4 Q 95.87% -8.49% 4.77% -52.82%
Acrivon Therapeutics Inc 3 Q - - - -20.66%
Acasti Pharma Inc 3 Q - - - -54.53%
Accustem Sciences Inc 2 Q - - - -
Acurx Pharmaceuticals inc 4 Q - - - -289.68%
Adc Therapeutics Sa 4 Q 96.36% -345.11% -69.05% -780.2%
Adial Pharmaceuticals Inc 3 Q - - - -234.06%
Aditxt Inc 3 Q 14.11% -7828.91% - -
Addex Therapeutics Ltd 4 Q - -1462.57% - -312.48%
Advaxis Inc 1 Q - -976% -3858% -29.54%
Aeon Biopharma inc 3 Q - - - -
Aeterna Zentaris Inc 4 Q 97.22% -402.96% - -15.79%
Kaya Holdings Inc 3 Q 62.57% - -110.04% -
Affimed N v 4 Q - -207.98% - -37.62%
Agex Therapeutics Inc 2 Q 44.44% -29766.67% - -
Agios Pharmaceuticals Inc 4 Q 91.75% -1350.7% - -38.08%
Agile Therapeutics Inc 3 Q 67.66% -12.92% 1.41% -
Ainos Inc 4 Q -559.7% -29765.38% -2438.38% -47.95%
Akebia Therapeutics Inc 4 Q 65.45% -0.08% -6.42% -
Akero Therapeutics Inc 3 Q - - - -26.11%
Akari Therapeutics Plc 4 Q - - - -991.1%
Akouos inc 3 Q - - - -45.09%
Albireo Pharma inc 3 Q 93.78% -384.46% - -97.59%
Aldeyra Therapeutics Inc 3 Q - - - -33.77%
Alimera Sciences Inc 4 Q 85.1% -14.19% 14.16% -65.83%
Alkermes Plc 3 Q 83.85% 12.54% -4.75% 18.33%
Allakos Inc 3 Q - - - -62.29%
Allarity Therapeutics Inc 3 Q - - - -
Alnylam Pharmaceuticals Inc 4 Q 83.63% -31.35% -50.11% -
Alpine Immune Sciences Inc 3 Q - -116.72% -150.3% -33.54%
Aileron Therapeutics Inc 3 Q - - - -90.99%
Altimmune inc 3 Q - -5710.22% -4280.94% -46.77%
Alx Oncology Holdings Inc 3 Q - - - -65.99%
Alzamend Neuro Inc 3 Q - - - -992.85%
Amylyx Pharmaceuticals Inc 3 Q 94.92% 20.35% -109.55% 0.49%
Ampio Pharmaceuticals inc 3 Q - - - -111.36%
Amphastar Pharmaceuticals Inc 3 Q 60.04% 27.26% 66.33% 23.93%
Amarin Corp Plcuk 3 Q 45.15% -29.23% 57.25% -9.12%
Amneal Pharmaceuticals Inc 4 Q 30.72% -15.11% 0.57% -42.4%
Applied Molecular Transport Inc 3 Q - - - -223.46%
Anaptysbio Inc 4 Q - -468.75% - -119.42%
Anebulo Pharmaceuticals Inc 4 Q - - - -109.4%
Ani Pharmaceuticals Inc 4 Q 59.42% 0.88% 21.3% 4.73%
Anixa Biosciences Inc 4 Q - - - -41.57%
Annexon Inc 3 Q - - - -71.47%
An2 Therapeutics Inc 3 Q - - - -58.99%
Annovis Bio inc 3 Q - - - -195.55%
Apexigen Inc 2 Q - - - -910.95%
Apellis Pharmaceuticals Inc 3 Q - -127.03% -148.41% -209.04%
Applied Therapeutics inc 4 Q - - - -
Aprea Therapeutics Inc 3 Q - - - -55.45%
Aptinyx Inc 1 Q - - - -157.89%
Aptevo Therapeutics Inc 3 Q - - - -89.48%
Aquestive Therapeutics Inc 4 Q 64.57% -61.42% -7.91% -
Aravive Inc 3 Q - - -1639.73% -
Arcturus Therapeutics Holdings Inc 3 Q - -35.94% -25.58% 34.11%
Aridis Pharmaceuticals Inc 4 Q - -526.55% - -
Ardelyx Inc 4 Q 84.85% -44.54% -23.78% -22.33%
Arcutis Biotherapeutics Inc 4 Q 83.39% - -141.01% -3.5%
Artelo Biosciences Inc 3 Q - - - -56.3%
Arvinas Inc 4 Q - - - -70.24%
Arrowhead Pharmaceuticals Inc 4 Q - -3812.33% -1485.05% -92.61%
Aslan Pharmaceuticals Limited 4 Q - - - -377.64%
Assembly Biosciences Inc 3 Q - - - -116.42%
Ascendis Pharma A 4 Q 76.28% -1139.63% - -221.45%
Assertio Holdings inc 4 Q 70.53% -173.97% -10.45% -158.86%
Atai Life Sciences N v 3 Q - - -74250.57% -28.83%
Alterity Therapeutics Limited 2 Q - - - 0%
Athersys Inc 3 Q - - - -
180 Life Sciences Corp 3 Q - - - -645.9%
Actinium Pharmaceuticals Inc 3 Q - - - -91.02%
Athenex Inc 4 Q 75.22% -425.38% -143.85% -
Atossa Therapeutics Inc 3 Q - - - -27.47%
Adhera Therapeutics Inc 2 Q - - - -
Avenue Therapeutics Inc 3 Q - - - -
Astria Therapeutics inc 4 Q - - - -34.74%
Aurinia Pharmaceuticals Inc 4 Q 88.04% -59.6% 5.5% -20.1%
Avadel Pharmaceuticals Plc 3 Q 98.33% -517.17% 26.03% -327.66%
Aveo Pharmaceuticals Inc 3 Q 86.98% -10.73% 23.74% -81.66%
Atea Pharmaceuticals Inc 3 Q - - - -21.49%
Avenir Wellness Solutions Inc 3 Q 71.83% -216.76% 1.36% -
Aerovate Therapeutics Inc 2 Q - - - -10.3%
Avalo Therapeutics Inc 3 Q -4.66% -2215.25% - -
Axim Biotechnologies Inc 3 Q - - -775.26% -
Axsome Therapeutics Inc 3 Q 88.7% -107.62% -35.56% -104.89%
Aytu Biopharma Inc 4 Q 72.98% -0.99% -1.96% -49.55%
Astrazeneca Plc 4 Q 81.95% 13.01% 13.46% 15.22%
Azitra Inc 4 Q - -2415.62% -1281.03% -
Bridgebio Pharma Inc 3 Q 85.38% -4387.39% - -
Atreca inc 3 Q - - - -200.73%
Briacell Therapeutics Corp 2 Q - - - 0%
Bicycle Therapeutics Plc 4 Q - -921.01% -856.57% -57.8%
Bioadaptives Inc 3 Q 29.71% -83.46% - -
Biodexa Pharmaceuticals Plc 4 Q - -1095.28% 0% -242.13%
Bullfrog Ai Holdings Inc 4 Q - - - 0%
Biofrontera Inc 4 Q - -0.48% -5.97% -154.77%
Beigene ltd 4 Q 83.44% -58.02% 16.59% -23.12%
Bausch Health Companies Inc 4 Q 71.14% -1.95% 7.56% -2468.69%
Biohaven Ltd 3 Q - - - -181.21%
Biora Therapeutics Inc 3 Q - - - -
Biovie Inc 4 Q - - - -341.34%
Bioxytran Inc 3 Q - - - -
Bellicum Pharmaceuticals Inc 3 Q - -76.15% -1589.62% -
Bellerophon Therapeutics inc 3 Q - - - -164.63%
Biolinerx Ltd 4 Q - - - -53.21%
Belite Bio Inc 4 Q - - - -34.98%
Biomea Fusion Inc 3 Q - - - -69.97%
Biomarin Pharmaceutical Inc 4 Q 79.03% 3.15% -4.69% 3.48%
Bristol myers Squibb Company 4 Q 76.08% 15.35% 34.43% 26.26%
Bionomics Limited 2 Q - -144450.3% 0% -96.08%
Benitec Biopharma Inc 4 Q - - - -204.34%
Bolt Biotherapeutics Inc 3 Q - -643.08% -161.83% -47.56%
Blueprint Medicines Corporation 4 Q - -142.61% 19.76% -191.56%
Bio path Holdings inc 4 Q - - - -375.74%
Bespoke Extracts Inc 3 Q 40.26% -123.37% -0.8% -
Bioxcel Therapeutics Inc 3 Q -50.15% -14805.28% -11021.7% -890.64%
Blue Water Biotech Inc 3 Q - - - -111.79%
Baudax Bio Inc 3 Q - - - -
Beyondspring Inc 4 Q - -2685.42% -5026.79% -
Calithera Biosciences Inc 4 Q - - - -107.94%
Calcimedica Inc 3 Q - - - -174.2%
Calliditas Therapeutics Ab 4 Q 98.11% -51.35% - -4.4%
Can fite Biopharma Ltd 4 Q - -1255.93% -478.77% -224.17%
Capricor Therapeutics inc 4 Q - -6.3% 47.24% -299.65%
Cara Therapeutics inc 4 Q 79.76% -1076.46% -369.51% -122.1%
Carisma Therapeutics Inc 3 Q - -1118.53% - -96.71%
Casi Pharmaceuticals inc 4 Q 63.28% -93.39% 46.03% -90.31%
Cymabay Therapeutics Inc 4 Q - -73512.28% -117119.3% -50.72%
Catalyst Biosciences Inc 3 Q - - - -
Chemocentryx Inc. 2 Q 96.59% -134.54% 16.23% -48.52%
Avid Bioservices Inc 3 Q -18.41% -37.53% 24.38% -6.11%
Conduit Pharmaceuticals Inc 3 Q - - - -
Celularity Inc 3 Q 85.29% -2479.56% -74.25% -144.18%
Chembio Diagnostics Inc 4 Q 45.78% -8.27% -27.8% -113.57%
Cen Biotech Inc 3 Q - -264.15% -94.3% -
Cerevel Therapeutics Holdings Inc 3 Q - - - -99.72%
Contrafect Corporation 3 Q - - - -
China Health Industries Holdings Inc 3 Q 0% -476.12% -90.8% -0.33%
Cincor Pharma Inc 3 Q - - - 0%
Cingulate Inc 3 Q - - - -
Checkpoint Therapeutics inc 3 Q - -18464.52% -33212.9% -
Caladrius Biosciences Inc 1 Q - - - -24.66%
Cell Source Inc 2 Q - - - -
Clene Inc 4 Q 77.65% -5984.12% -7818.82% -361.99%
Cellectar Biosciences inc 3 Q - - - -1632.54%
Clearside Biomedical Inc 3 Q 83.47% -1078.81% -722.12% -
Clever Leaves Holdings Inc 3 Q 66.01% -174.64% 47.48% -118.25%
Clovis Oncology inc 3 Q 76.31% -182.68% -118.25% -
Chemomab Therapeutics Ltd 1 Q - - - 77.93%
Clearmind Medicine Inc 3 Q - - - -876.57%
Compass Pathways Plc 4 Q - - - -58.72%
Comera Life Sciences Holdings Inc 3 Q 69.22% -1580.01% - -
Chimerix Inc 4 Q - -454025% - -37.93%
Cnbx Pharmaceuticals Inc 4 Q - -199.61% -53.72% -
Concert Pharmaceuticals Inc 3 Q - -361300% -550700% -165.03%
Cns Pharmaceuticals Inc 3 Q - -35106.69% -26156.21% -615.33%
Centessa Pharmaceuticals Plc 3 Q - - - -54.03%
Connect Biopharma Holdings Limited 4 Q - - - -72.67%
Context Therapeutics Inc 3 Q - - - -78.39%
Cocrystal Pharma Inc 2 Q - - - -51.18%
Cogent Biosciences Inc 3 Q - - - -62.85%
Collegium Pharmaceutical Inc 4 Q - - -459.2% 25.52%
Corcept Therapeutics Inc 4 Q 98.61% 23.01% 17.54% 21.98%
Coya Therapeutics Inc 3 Q - - - 0%
China Pharma Holdings Inc 3 Q -12.93% -43.12% 25.95% -64.06%
Cumberland Pharmaceuticals Inc 4 Q 83.64% -67.38% -1.99% -18.38%
Cannapharmarx Inc 3 Q - - - -
Catalyst Pharmaceuticals Inc 4 Q 85.7% 31.51% 15.07% 19.76%
Corbus Pharmaceuticals Holdings Inc 3 Q - - - -320.25%
Cormedix Inc 3 Q - - - -65.98%
Crinetics Pharmaceuticals Inc 3 Q - -16606.36% - -57.04%
Cervomed Inc 3 Q - - - 0%
Corvus Pharmaceuticals Inc 3 Q - - - -60.76%
Cti Biopharma Corp 1 Q 94.92% -55.66% -25.75% -
Innovation Pharmaceuticals Inc 3 Q - - - -116.47%
Catalent Inc 4 Q 16.7% -20.12% 1.95% -30.92%
Cytomx Therapeutics Inc 3 Q - 11.34% -119.44% -
Citius Pharmaceuticals Inc 4 Q - - - -42.88%
Cue Biopharma Inc 3 Q - -524.05% 85.24% -99.14%
Cadrenal Therapeutics Inc 3 Q - - - -
Cv Sciences Inc 3 Q 47.96% -11.63% -1.22% 56.96%
Cohbar Inc 2 Q - - - -88.89%
Celyad Oncology Sa 4 Q - - - -614.13%
Cyclacel Pharmaceuticals Inc 3 Q - -37387.5% -26375% -278.19%
Cyclerion Therapeutics Inc 1 Q - -1825.32% -1805.34% -99.04%
Cytodyn inc 4 Q - - - -
Cryoport inc 4 Q 40.62% -112.45% -22.93% -20.19%
Cyteir Therapeutics Inc 3 Q - - - -24.88%
Cytokinetics Incorporated 3 Q - -34238.62% - -
Altamira Therapeutics Ltd 4 Q -372.44% -8680.31% 0% -
Dar Bioscience Inc 3 Q - -829.91% 56.53% -1482.44%
Day One Biopharmaceuticals Inc 3 Q - - - -7.66%
Decibel Therapeutics Inc 2 Q - - - -84.03%
Deciphera Pharmaceuticals Inc 4 Q 96.3% -97.71% -53.26% -49.44%
Journey Medical Corporation 3 Q 81.39% 48.61% 22.49% -118.05%
Dice Therapeutics Inc 2 Q - - - -22.01%
Diamedica Therapeutics Inc 3 Q - - - -41.26%
Dmk Pharmaceuticals Corporation 3 Q -3635.25% -15317.21% - -
Dianthus Therapeutics Inc 3 Q - -1597.73% - -61.77%
Dermata Therapeutics Inc 3 Q - - - -102.71%
Durect Corp 3 Q 82.11% -172.88% - -243.4%
Bright Minds Biosciences Inc 3 Q - - - -111.73%
Design Therapeutics Inc 3 Q - - - -23.69%
Dynavax Technologies Corporation 3 Q 80.69% 20.86% -105.46% 10.46%
Dyne Therapeutics Inc 3 Q - - - -97.57%
Emergent Biosolutions Inc 4 Q 33.68% -19.14% 8.67% -86.78%
Edesa Biotech Inc 4 Q - - - -103.79%
Effector Therapeutics Inc 3 Q - - - -
Eagle Pharmaceuticals inc 2 Q 73.92% 7.99% -10.12% 4.98%
Elevai Labs Inc 3 Q 66.01% -141.18% -122.25% -
Elanco Animal Health Inc 4 Q 50.14% -13.62% -1.64% -18.07%
Eledon Pharmaceuticals Inc 3 Q - - - -101.74%
Elite Pharmaceuticals Inc 1 Q 47.96% 33.71% 17.31% 40.81%
Elicio Therapeutics Inc 3 Q - - - -100.2%
Enliven Therapeutics Inc 3 Q - - - -8.69%
Eliem Therapeutics Inc 3 Q - - - -33.55%
Emmaus Life Sciences Inc 3 Q 95.74% 1.34% 2.87% -
Endo International Plc 4 Q 49.87% -490.52% -9.17% -
Enlivex Therapeutics Ltd 4 Q - - - -54.64%
Ensysce Biosciences Inc 4 Q - - -403.22% -
Enanta Pharmaceuticals Inc 3 Q - -148.46% -51.71% -52.23%
Enveric Biosciences Inc 3 Q - - - -278.69%
Evolus Inc 4 Q 68.41% -19.4% 39.6% -
Essa Pharma inc 4 Q - - - -17.41%
Epizyme Inc. 2 Q 81.22% -129.85% -23.09% -
Equillium Inc 3 Q - -41.83% 98.74% -29.28%
Eqrx Inc 3 Q - - - -20.27%
Erasca Inc 3 Q - - - -58.93%
Eterna Therapeutics Inc 4 Q -288.24% -36194.12% - -508.61%
Esperion Therapeutics inc 4 Q - -174.71% -101.04% -
89bio Inc 3 Q - - - -34.92%
Eton Pharmaceuticals Inc 4 Q 47.31% -29.41% -8.89% -6.21%
Earth Science Tech Inc 1 Q 44.24% -83.86% 13.46% -
Entasis Therapeutics Holdings Inc 1 Q - - - -145.48%
Evofem Biosciences Inc 3 Q 63.05% - -4.42% -
Evelo Biosciences Inc 3 Q - - - -
Evotec Se 4 Q 23.16% -23.38% 56.24% -14.8%
Evoke Pharma Inc 3 Q - -108.39% -66.65% -517.96%
Edgewise Therapeutics inc 4 Q - - - -32.06%
Eyenovia inc 3 Q 0% -612582.05% - -171.3%
Fortress Biotech Inc 3 Q 81.5% -30.86% -41.62% -1797.17%
Forte Biosciences Inc 3 Q - - - -88.96%
Fibrogen Inc 3 Q 89.43% -158.51% -78.91% -
Foghorn Therapeutics Inc 4 Q - -417.85% - -
Homology Medicines Inc 3 Q - - - -97.6%
Flora Growth Corp 3 Q 28.54% 6.48% 0.81% 0%
Amicus Therapeutics inc 4 Q 89.59% -29.22% -13.98% -119.46%
Frequency Therapeutics Inc 3 Q - - - -115.97%
F star Therapeutics Inc 3 Q - -1636.18% -1470.4% -56.71%
Fulcrum Therapeutics Inc 3 Q - -3164.3% -511.99% -38.48%
First Wave Biopharma Inc 3 Q - - - 412.15%
Galectin Therapeutics Inc 3 Q - - - -
Gain Therapeutics inc 3 Q - - - -169.47%
Generation Bio Co 4 Q - -1222.59% -931.72% -52.29%
Global Blood Therapeutics Inc. 2 Q 98.03% -115.26% -182.63% -170.37%
The Greater Cannabis Company Inc 2 Q - - - -
Geron Corp 3 Q - -27320.12% -15971.34% -70.26%
Gh Research Plc 4 Q - - - -16.25%
Guardion Health Sciences Inc 3 Q 59.35% 15.15% -28.81% -117.06%
Galmed Pharmaceuticals Ltd 4 Q - - - 133.1%
Galapagos Nv 4 Q 97.61% -43.14% 0% -4.09%
Gelesis Holdings Inc 2 Q 55.01% -693.86% - -
Greenwich Lifesciences Inc 1 Q - - - -7.58%
Galecto Inc 3 Q - - - -95.14%
Glycomimetics Inc 3 Q - - - -96.33%
Genelux Corporation 1 Q - -6096.47% - -
Genprex Inc 3 Q - - - -194.71%
Gossamer Bio Inc 4 Q - - - -944.79%
Geovax Labs Inc 3 Q - - - -125.46%
Structure Therapeutics Inc 4 Q - - - -32.69%
Gracell Biotechnologies Inc 4 Q - - - -44.16%
Grifols Sa 4 Q - - - 3.21%
Gri Bio Inc 3 Q - - - -595.6%
Galera Therapeutics Inc 3 Q - - - -
Globestar Therapeutics Corporation 4 Q - - - -
Gt Biopharma Inc 3 Q - - - -87.8%
G1 Therapeutics Inc 4 Q - -73.14% -137.19% -106.04%
Hutchmed china Limited 4 Q 60.38% 12.06% -14.21% 13.6%
Hcw Biologics Inc 3 Q 20.49% -578.9% - -64.43%
Hepion Pharmaceuticals inc 3 Q - - - -137.96%
Humanigen Inc 1 Q - -1892.31% -3194.12% -
Hookipa Pharma inc 3 Q - -277.65% -404.78% -70.24%
Hoth Therapeutics Inc 3 Q - -37187.36% - -102.76%
Werewolf Therapeutics Inc 4 Q - -799.67% - -32.25%
Inhibitor Therapeutics Inc 2 Q - - - 229.02%
Harmony Biosciences Holdings inc 4 Q 74.35% 15.79% -7.67% 27.47%
Harrow Inc 3 Q 70.76% -12.84% - -38.87%
Heron Therapeutics Inc 3 Q 42.36% -80.09% 68.52% -
Hst Global Inc 3 Q - - - -
Histogen Inc 3 Q - -77080% -53720% -136.2%
Fsd Pharma Inc 4 Q - - - -77.29%
Horizon Therapeutics Public Limited Company 2 Q 76.8% 13.46% 16.21% 8.54%
Ibio inc 3 Q - -11492% -5636% -324.84%
Intercept Pharmaceuticals inc 3 Q 99.78% -3.14% -37.96% -82.24%
Ideaya Biosciences Inc 3 Q - -341.38% - -24.39%
Inflarx N v 4 Q - - - -33.37%
Igc Pharma Inc 4 Q 65.2% -2739.71% -807.84% -110.37%
Igm Biosciences Inc 3 Q - -12178.59% - -91.73%
Intelgenx Technologies Corp 3 Q - -867.61% -202.52% -
I mab 4 Q - - - -86.16%
Immunogen inc 3 Q - 27.11% 29.58% -22.11%
Imago Biosciences Inc 3 Q - - - -13.66%
Immutep Limited 2 Q - -767.22% - -29.23%
Immix Biopharma Inc 2 Q - - - -45.4%
Immunome Inc 3 Q - -121.88% - -253.18%
Imunon Inc 3 Q - - - -116.61%
Impel Pharmaceuticals Inc 3 Q 58.27% -288.21% -217.42% -
Immuron Limited 2 Q 88.43% -255.78% - -19.3%
Immuneering Corporation 4 Q - - - -52.49%
Biostax Corp 3 Q - - - -
Immunic Inc 4 Q - - - -157.44%
Integrated Biopharma Inc 4 Q 4.94% -3.63% -17.7% -2.05%
Intercure Ltd 4 Q 39.9% 11.26% 9.75% 8.39%
Indaptus Therapeutics Inc 4 Q - - - -81.61%
Indivior Plc 4 Q 82.98% 0.18% 0% -
Infinity Pharmaceuticals Inc 2 Q - -1707.72% - -
Inmed Pharmaceuticals Inc 4 Q 26.14% -119.19% - -77.75%
Insmed Inc 4 Q 78.47% -217.2% -5.53% -
Inozyme Pharma Inc 3 Q - - - -55.93%
Io Biotech Inc 3 Q - - - -60.91%
Ionis Pharmaceuticals Inc 4 Q 99.77% 2.79% 12.45% -63.15%
Immunoprecise Antibodies Ltd 1 Q 55.95% -128.53% 0% -45.95%
Intellipharmaceutics International Inc 4 Q - -4400.55% - -
Disc Medicine Inc 3 Q - - - -26%
Ironwood Pharmaceuticals inc 4 Q - -1.48% -16.42% -
International Stem Cell Corporation 3 Q 60.42% -6.64% 2.43% -
Iveric Bio Inc 1 Q - - - -57%
Intra cellular Therapies Inc 4 Q - -21.63% 36.61% -23.02%
Iterum Therapeutics Plc 3 Q - -29.37% -67.57% -216.28%
Inventiva S a 4 Q - -445.64% - -109.15%
Incannex Healthcare Inc 4 Q - - - -
Jaguar Health inc 3 Q 81.73% -280.98% -192% -1205.31%
Janone Inc 3 Q - - - 101.35%
Janux Therapeutics Inc 3 Q - -459.59% -657.57% -19.56%
Jazz Pharmaceuticals Plc 4 Q - 9.3% 16.86% 11.78%
Johnson and Johnson 4 Q 75.32% 29.92% 15.75% 48.95%
Kineta Inc 3 Q - - - -1994.91%
Kala Bio inc 3 Q - - - -260.94%
Kalvista Pharmaceuticals Inc 3 Q - - - -67.13%
Chinook Therapeutics Inc 2 Q - -6641.27% - -58.28%
Kamada Ltd 4 Q 38.94% 5.81% 0% 3.39%
Kiniksa Pharmaceuticals ltd 4 Q 88.51% 30.26% -11.84% 3.42%
Kinnate Biopharma Inc 3 Q - - - -62.31%
Kiora Pharmaceuticals Inc 3 Q - - - -117.7%
Karyopharm Therapeutics Inc 3 Q 97.47% -95.83% -103.49% -
Kronos Bio Inc 3 Q - -3421.37% -2003.71% -55.93%
Keros Therapeutics Inc 4 Q - -270.12% - -46.74%
Karuna Therapeutics Inc 3 Q - - - -29.58%
Kintara Therapeutics Inc 3 Q - - - -573.13%
Pasithea Therapeutics Corp 3 Q - - - -44.04%
Kura Oncology Inc 3 Q - - - -33.54%
Kazia Therapeutics Limited 2 Q - -2046500% - -169.83%
Kezar Life Sciences Inc 3 Q - -330.04% -23.01% -36.18%
Longboard Pharmaceuticals Inc 3 Q - - - -83.25%
Lannett Company Inc 1 Q 19.1% -127.69% -11.72% -
Lexaria Bioscience Corp 4 Q 96.81% -783.35% - -214.52%
Lifevantage Corp 4 Q 78.66% -1.27% -2.08% 9.5%
Ligand Pharmaceuticals Incorporated 3 Q 74.94% -31.26% -26.13% 2.56%
Longeveron Inc 3 Q 36% -3404% -520% -147.9%
Lianbio 3 Q - - - -0.33%
Lftd Partners Inc 3 Q 33.74% 4.71% 7.88% 7.41%
Lipella Pharmaceuticals Inc 4 Q - -570.07% - -150.11%
Lixte Biotechnology Holdings Inc 3 Q - - - -134.89%
Eli Lilly And Company 4 Q 80.88% 23.41% 4.68% 46.98%
Landec Corporation 1 Q 26.27% -24.29% 1.44% -36.52%
Lipocine Inc 4 Q - -2519.07% - -63.28%
Leap Therapeutics inc 4 Q - - - -133.17%
Liquidia Corporation 4 Q 78.08% -605.83% - -132.16%
Larimar Therapeutics Inc 3 Q - - - -32.58%
Lucy Scientific Discovery Inc 4 Q 60.06% -27050.05% -273.59% -109.81%
Lantern Pharma Inc 2 Q - - - -26.42%
Lumos Pharma Inc 4 Q - -1144.92% -57.99% -85.63%
Lexicon Pharmaceuticals Inc 3 Q 95.68% -31188.27% -50095.68% -118.9%
Lyell Immunopharma Inc 4 Q - -407153.85% -1081276.92% -32.66%
Merrimack Pharmaceuticals Inc 3 Q - - - -15.88%
Maia Biotechnology Inc 3 Q - - - -91.44%
Mustang Bio inc 3 Q - - - -133.38%
Moleculin Biotech Inc 3 Q - - - -60.64%
Seres Therapeutics Inc 3 Q - -15436.77% -19228.71% -
Madrigal Pharmaceuticals Inc 4 Q - - - -219.39%
Medicenna Therapeutics Corp. 1 Q - - - -
23andme Holding Co 4 Q 45.38% -632.68% -31.79% -87.29%
Mei Pharma Inc 3 Q - 86.33% -20.73% 87.24%
Macrogenics Inc 4 Q 98.48% -429.78% - -5.77%
Mira Pharmaceuticals Inc 2 Q - - - -
Mirum Pharmaceuticals Inc 3 Q - -49.42% 12.22% -104.1%
Milestone Pharmaceuticals Inc 3 Q - - - -125.27%
Moonlake Immunotherapeutics 4 Q - - - -11.29%
Mineralys Therapeutics Inc 3 Q - - - -
Mallinckrodt Plc 3 Q 30.35% -347.18% -11.8% -453.63%
Mannkind Corporation 3 Q 79.98% 3.36% -6.18% -
Medicinova Inc 3 Q - -72.31% -136.89% -14.21%
Monopar Therapeutics Inc 3 Q - - - -113.31%
Morphosys Ag 4 Q 75.51% -79.63% 46.08% -386.82%
Morphic Holding inc 4 Q - - - -23.62%
Medicure Inc 4 Q 69.69% 5.92% 11.78% 6.5%
Mereo Biopharma Group Plc 4 Q - - - 20.57%
Merck and Co Inc 3 Q 73.29% 29.76% 18.53% 10.67%
Marker Therapeutics inc 3 Q - -1157.57% -251.62% -52.15%
Marinus Pharmaceuticals Inc 3 Q 93.8% -449.33% - -169.08%
Mersana Therapeutics Inc 4 Q - -182.64% -109.54% -282.36%
Mirati Therapeutics Inc 3 Q - -987.22% - -82.15%
Merus N v 3 Q - -208.57% - -63.39%
Maravai Lifesciences Holdings Inc 3 Q 45.13% -22.59% -0.85% 6.57%
Musclepharm Corporation 1 Q 11.52% -48.1% -5.26% -
Metacrine Inc 3 Q - - - -83.77%
Molecular Templates inc 3 Q - 61.11% - -
Matinas Biopharma Holdings Inc 2 Q - - - -58.38%
Mural Oncology Plc 3 Q - - - -
Mainz Biomed N v 4 Q 34.38% -4979.9% 0% -187.2%
Myovant Sciences Ltd 4 Q 92.6% -57.5% -95.85% -
Innovation1 Biotech Inc 3 Q - - - -3806.7%
Nature s Sunshine Products inc 4 Q 70.8% 8.45% 5.73% 10.81%
Nascent Biotech Inc 4 Q - - - -
Nabriva Therapeutics Plc 2 Q -304.55% -537.76% 14.89% -2673.17%
Neubase Therapeutics inc 3 Q - - - -103.52%
Nanobiotix S a 4 Q - -1194.33% - -
Novabay Pharmaceuticals Inc 3 Q 64.76% -61.91% -33.19% -225.86%
Nucana Plc 4 Q - - - -105.28%
Neptune Wellness Solutions Inc 4 Q 13.62% -252.25% -46.29% -
Minerva Neurosciences Inc 3 Q - - - -
Neximmune Inc 3 Q - - - -216.32%
Ngm Biopharmaceuticals Inc 4 Q - -16769.7% - -77.85%
Nighthawk Biosciences inc 3 Q 24.63% -1979.19% -65.57% -100.3%
Nektar Therapeutics 3 Q 48.51% -189.85% 58.78% -121.87%
Nkarta Inc 3 Q - - - -36.69%
Nls Pharmaceutics Ltd 4 Q - - - -502.79%
Neoleukin Therapeutics Inc 3 Q - - - -24.54%
9 Meters Biopharma Inc 1 Q - - - -584.98%
Nanomix Corp 4 Q - - - -
Nanoviricides inc 4 Q - - - -63.96%
Novan Inc 1 Q 59.41% -445.96% -5.62% -616.76%
Neurobo Pharmaceuticals Inc 3 Q - - - -53.18%
Nurix Therapeutics Inc 4 Q - -276.77% 81.29% -59.47%
Nrx Pharmaceuticals Inc 3 Q - - - -
Rebus Holdings Inc 2 Q - - - -
Nuvation Bio Inc 3 Q - - - -13.09%
Nuvalent Inc 3 Q - - - -26.46%
Nuvectis Pharma inc 1 Q - - - -
Novartis Ag 4 Q 73.27% 31.83% 26.59% 31.77%
Northwest Biotherapeutics inc 3 Q - -4704.19% - -
Nexien Biopharma Inc 2 Q - - - -
Nextcure Inc 3 Q - - - -44.7%
Theralink Technologies Inc 4 Q 36.93% -22688.34% -1159.89% -
Obseva Sa 4 Q - -107.3% -255.45% 0%
Oculis Holding Ag 4 Q - -4243.2% 0% -
Ocular Therapeutix Inc 4 Q 90.64% -197.41% - -288.91%
Ocuphire Pharma Inc 3 Q - 46.59% 19.88% 65.54%
Oragenics Inc 2 Q - -23175.46% - -104.87%
Organigram Holdings Inc 3 Q 21.65% -9.8% 0% -5.26%
Organon and Co 4 Q 57.26% 34.17% 17.46% -
Olema Pharmaceuticals inc 3 Q - - - -47.48%
Omeros Corp 3 Q - - - 54.32%
Oncorus Inc 1 Q - - - -134.31%
Oncosec Medical Incorporated 4 Q - - - -868.37%
Oncternal Therapeutics Inc 3 Q - -5509.5% -506.7% -85.29%
Oncolytics Biotech Inc 4 Q - - - -100.69%
Onconova Therapeutics inc 3 Q - -8314.04% -7868.42% -87.66%
Opko Health Inc 3 Q 40.44% -47.3% 17.09% -13.63%
Opiant Pharmaceuticals Inc 3 Q - -5703.35% -2759.19% -97.18%
Optinose Inc 4 Q 89.27% -49.91% 34.43% -
Organogenesis Holdings Inc 3 Q 76.24% 2.92% 8.58% 4.45%
Orgenesis Inc 2 Q 53.66% 52.49% -36.17% 37.77%
Oric Pharmaceuticals Inc 3 Q - - - -39.61%
Oramed Pharmaceuticals Inc 3 Q - - - 10.27%
Otonomy Inc 3 Q - - - -137.86%
Oncotelic Therapeutics Inc 3 Q - 58.66% - -103.77%
Ovid Therapeutics Inc 4 Q - -10823.47% -21471.07% -49.76%
One World Products Inc 3 Q 28.18% -2971.89% -50.29% -
Phibro Animal Health Corporation 4 Q 31.49% 0.51% -4.08% 5.39%
Prestige Consumer Healthcare Inc 4 Q 56.02% 43.49% 1.26% -5.12%
Panbela Therapeutics Inc 3 Q - - - -
Puma Biotechnology Inc 3 Q 76.33% 10.33% 38.84% 12.75%
Rapid Therapeutic Science Laboratories Inc 2 Q - - - -
Pacira Biosciences inc 3 Q 75.75% 6.62% 7.51% 0.88%
Processa Pharmaceuticals Inc 2 Q - - - -233.27%
Procyon Corporation 4 Q 78.06% -20.21% -11.22% -11.73%
Pds Biotechnology Corp 3 Q - - - -144.23%
Pepgen Inc 3 Q - - - -47.97%
Pfizer Inc 4 Q 46.93% -23.58% -2.22% 2.23%
Precigen Inc 3 Q -11.46% -1435.46% -479.84% -54.48%
Pharming Group N v 4 Q 91.46% 6.65% 99.77% 7.82%
Phasebio Pharmaceuticals Inc. 2 Q - -8012.02% -5232.69% -
Phathom Pharmaceuticals Inc 3 Q - - - -
Phio Pharmaceuticals Corp 3 Q - - - -132.27%
Pharvaris N v 4 Q - - - -28.63%
Pieris Pharmaceuticals Inc 3 Q - -55.08% -61.7% -98.12%
Peak Pharmaceuticals Inc 4 Q - - - -
Protokinetix Incorporated 3 Q - - - -413.38%
Pliant Therapeutics Inc 3 Q - - - -32.5%
Plx Pharma Inc 3 Q -278.24% -2201.3% -2563.73% -114.93%
Promis Neurosciences inc 3 Q - - - -
Pmv Pharmaceuticals Inc 3 Q - - - -31.15%
Point Biopharma Global Inc 3 Q - -887.97% -1279.07% 21.1%
Purple Biotech Ltd 4 Q - - - 46.2%
Propanc Biopharma Inc 2 Q - - - -
Praxis Precision Medicines Inc 4 Q - -5219.03% -3841.75% -151.02%
Pardes Biosciences Inc 2 Q - - - -43.36%
Perrigo Company Plc 4 Q 36.9% -2.79% 13.21% -0.26%
Prelude Therapeutics Inc 3 Q - - - -14.66%
Procaps Group S a 4 Q 58.44% 10.38% 0% -
Prophase Labs Inc 3 Q 27.95% -61.74% -37.49% -17.51%
Proqr Therapeutics N v 4 Q - - - 0%
Prothena Corporation Public Limited Company 4 Q - -21353.16% -16476.9% -24.84%
Puretech Health Plc 4 Q - -237.32% - -6.77%
Portage Biotech Inc. 1 Q - - - -12.99%
Paratek Pharmaceuticals Inc 1 Q 80.01% -64.49% 34.51% -
Provention Bio Inc 4 Q - -307.75% -539.56% -103.36%
Ptc Therapeutics inc 4 Q - -50.74% - -
Protagonist Therapeutics inc 4 Q - 45.56% -73% -27.49%
Protagenic Therapeutics Inc new 2 Q - - - -40.73%
Palatin Technologies Inc 4 Q 95.2% -385.62% - -
Petros Pharmaceuticals inc 3 Q 75.61% -271.67% - -
Pulmatrix Inc 2 Q - -345.23% -347.78% -57.48%
Provectus Biopharmaceuticals Inc 3 Q - -1112.59% 73.2% -
Powerup Acquisition Corp 4 Q - - - -
Paxmedica Inc 4 Q - - - -956.79%
Pyxis Oncology Inc 3 Q - - - -63.26%
Q Biomed inc 1 Q - - - -
Qualigen Therapeutics Inc 3 Q - - - -477.12%
Qilian International Holding Group Limited 3 Q 3.83% -17.75% 1.62% -18.31%
Uniqure N v 3 Q - -6366.1% -20194.46% -60.49%
Rain Oncology Inc 3 Q - - - -82.96%
Rani Therapeutics Holdings Inc 3 Q - - - -130.24%
Rapt Therapeutics Inc 3 Q - - - -51.96%
Ultragenyx Pharmaceutical Inc 3 Q 88.79% -162.82% -29.64% -346.34%
Actavia Life Sciences Inc 4 Q - -36097.07% -13643.77% -
Rocket Pharmaceuticals Inc 3 Q - - - -53.4%
Arcus Biosciences Inc 4 Q - -261.29% -183.87% -57.17%
Redhill Biopharma Ltd 4 Q 46.06% - 47.4% -
Dr Reddy s Laboratories Limited 1 Q 56.65% 18.32% 0% 19.5%
Regeneron Pharmaceuticals Inc 4 Q 91.07% 33.77% 16.82% 16.07%
Renovaro Inc 4 Q - - - -81.25%
Reata Pharmaceuticals Inc 2 Q - - -158.7% -
Revelation Biosciences Inc 3 Q - - - 11.18%
Regen Biopharma Inc 4 Q - -1105.44% 10.94% -
Regulus Therapeutics Inc 3 Q - - - -90.69%
Regenerx Biopharmaceuticals inc 1 Q - -2007.3% -986.62% -
Rigel Pharmaceuticals Inc 3 Q 95.49% -20.23% -12.08% -
Relmada Therapeutics Inc 3 Q - - - -93.37%
Rallybio Corporation 4 Q - - - -56.9%
Rockwell Medical inc 3 Q 9.49% -8.07% -5.17% -61.48%
Avidity Biosciences Inc 4 Q - -2756.18% - -39.74%
Cartesian Therapeutics Inc 4 Q - - - -
Transcode Therapeutics Inc 3 Q - - - -821.81%
Renovorx Inc 3 Q - - - -345.27%
Roivant Sciences Ltd 4 Q - - - 160.44%
Reneo Pharmaceuticals Inc 3 Q - - - -62.08%
Royalty Pharma Plc 4 Q - - -77.08% 17.3%
Repare Therapeutics Inc 3 Q - -874.43% -378.65% -38.6%
Respirerx Pharmaceuticals Inc 2 Q - - - -
Rvl Pharmaceuticals Plc 2 Q 86.32% -326.71% -184.37% -155.18%
Revance Therapeutics Inc 4 Q 77.91% - -60.16% -
Reviva Pharmaceuticals Holdings Inc 3 Q - - - -1344.44%
Prometheus Biosciences Inc 1 Q - -3699.19% -19388.87% -33.5%
Rhythm Pharmaceuticals inc 3 Q 89.28% -196.25% -227.03% -94.1%
Rayzebio Inc 3 Q - - - -
Rezolute Inc 4 Q - - - -51.81%
Sage Therapeutics Inc 3 Q 66.68% -7423.78% - -62.67%
Cassava Sciences Inc 4 Q - - - -57.53%
Sunshine Biopharma Inc 3 Q 33.41% -10.94% -8.43% -111.3%
Scpharmaceuticals Inc 3 Q 71.58% -411.85% -956.48% -77.06%
Scopus Biopharma Inc 2 Q - - - -
Societal Cdmo Inc 3 Q 15.77% -19.47% 14.64% -37.93%
Scynexis Inc 3 Q - -99.77% -788.64% 182.33%
Schrodinger Inc 4 Q 77.68% -41.4% -127.62% 7.04%
Seelos Therapeutics inc 4 Q - -820% 61.95% -
Sangui Biotech International Inc 1 Q - -205.74% -12.47% -
Sagimet Biosciences inc 3 Q - -317.65% - -
Sigilon Therapeutics Inc 2 Q - -127.22% -366.66% -83.83%
Shuttle Pharmaceuticals Holdings Inc 4 Q - - - -156.17%
Siga Technologies Inc 4 Q 87.29% 62.03% 67.85% 44.84%
Sio Gene Therapies Inc 4 Q - - - -55.94%
Skinvisible Inc 3 Q - -5750.36% -56.34% -
Skye Bioscience Inc 3 Q - - - -
Sol gel Technologies Ltd 4 Q - -1752.77% - -70.48%
Acelyrin Inc 3 Q - - - -
Salarius Pharmaceuticals inc 3 Q - - - -236.94%
Sellas Life Sciences Group Inc 3 Q - - - -805.32%
Summit Therapeutics Inc 4 Q - - - -571.82%
Syndax Pharmaceuticals Inc 3 Q - - - -42.37%
Soligenix inc 4 Q 9.5% -743.38% -756.65% -268.25%
Sonoma Pharmaceuticals Inc 4 Q 46.53% -27.6% 8.57% -73.6%
Synaptogenix Inc 3 Q - - - 34.96%
Sensei Biotherapeutics Inc 3 Q - - - -44.68%
Sanofi 4 Q 69.35% 11.7% 21.74% 7.31%
Sonnet Biotherapeutics Holdings Inc 4 Q - -6273.54% - -1067.83%
Spectrum Pharmaceuticals Inc 1 Q 93.19% -32.07% 76.88% -209.59%
Spruce Biosciences Inc 3 Q - -402.02% 42.92% -54.81%
Scisparc Ltd 4 Q 76.1% - - 40.19%
Spero Therapeutics Inc 3 Q - -12.58% 63.34% -2.59%
Ars Pharmaceuticals Inc 3 Q - - - -7.83%
Sarepta Therapeutics Inc 3 Q - -12.34% -93.39% -106.15%
Sierra Oncology Inc 1 Q - - - -76.49%
Statera Biopharma Inc fka Cytocom Inc 3 Q 74.74% -500.68% 0% -
Stoke Therapeutics Inc 3 Q - -741.9% -62.97% -54.29%
Satsuma Pharmaceuticals Inc 1 Q - - - -115.24%
Shattuck Labs Inc 3 Q - -4014.72% -4557% -64.97%
Supernus Pharmaceuticals inc 3 Q 87.26% -10.38% 45.67% 2.82%
Sunwin Stevia International Inc. 2 Q 14.99% -2.52% 8.06% -106.36%
Sinovac Biotech Ltd 4 Q 54.15% 5.9% - 0.69%
Savara Inc 3 Q - - - -44.42%
60 Degrees Pharmaceuticals Inc 2 Q -209.04% -5616.46% -412.88% -
Synlogic Inc 3 Q - -3073.28% -5527.99% -95.3%
Spyre Therapeutics Inc 4 Q - - - -
Syros Pharmaceuticals Inc 3 Q - -1067.07% -85.67% -122.04%
Takeda Pharmaceutical Company Limited 1 Q 69.11% 7.87% 20.57% 4.99%
Taro Pharmaceutical Industries Ltd 1 Q 46.83% 4.44% 16.03% 1.47%
Theravance Biopharma inc 3 Q - -57.03% -216.09% -17.05%
Tricida Inc 3 Q - - - -
Alaunos Therapeutics Inc 3 Q - - - -140.74%
Tenx Keane Acquisition 4 Q - - - 0%
Tenax Therapeutics Inc 3 Q - - - 69.85%
Terns Pharmaceuticals Inc 3 Q - - - -30.99%
Teva Pharmaceutical Industries Limited 4 Q 54.22% 9.72% 21.93% -7.7%
Tff Pharmaceuticals Inc 3 Q - -1878.17% - -83.82%
Tg Therapeutics Inc 3 Q 97.88% 68.71% 32.5% -35.58%
Tharimmune Inc 4 Q - - - -171.08%
Third Harmonic Bio Inc 3 Q - - - 5.62%
Thorne Healthtech Inc 2 Q 55.89% 5.96% 0.87% 13.58%
Theseus Pharmaceuticals Inc 3 Q - - - -24.84%
Theratechnologies Inc 4 Q 75.99% -29.3% 47.69% -
Talphera Inc 4 Q - - - -
Tiziana Life Sciences Ltd 4 Q - - - -78.67%
Timber Pharmaceuticals Inc 2 Q - -29367.95% -19196.18% -516.88%
Tango Therapeutics Inc 3 Q - -207.45% -70.06% -41.41%
Tonix Pharmaceuticals Holding Corp 3 Q 40.49% -701.3% -449.84% -67.1%
Theriva Biologics inc 3 Q - - - -34.16%
Tempest Therapeutics Inc 3 Q - - - -378.21%
Turning Point Therapeutics Inc. 2 Q - -103435.29% -16289.92% -37.45%
Entrada Therapeutics Inc 4 Q - -73.49% 37.56% 2.32%
Trevi Therapeutics Inc 3 Q - - - -27.17%
Trevena inc 3 Q - - - -314.87%
2seventy Bio Inc 4 Q - -531.84% -144.63% -65.41%
Travere Therapeutics Inc 4 Q - - - -56.68%
Therapeuticsmd Inc 3 Q - - - 216.13%
Neuropathix Inc. 1 Q - -767.19% 41.6% -
Tyme Technologies Inc. 2 Q - - - -29.11%
Tyra Biosciences Inc 3 Q - - - -24.48%
Unity Biotechnology Inc 3 Q - - - -94.34%
Unicycive Therapeutics Inc 3 Q - - - -
Universe Pharmaceuticals Inc 3 Q 31.93% -19.08% -7.32% -15.59%
Urogen Pharma Ltd 4 Q 88.59% -108.49% -101.34% -
United Therapeutics Corporation 4 Q 88.45% 35.32% 16.27% 17.72%
Vaccitech Plc 2 Q - -7132.93% -5478.44% -23.44%
Avricore Health Inc 4 Q 25.83% -46.27% 17.12% -41.66%
Vaxxinity Inc 3 Q - - - -172.68%
Vbi Vaccines Inc 3 Q - -321.65% - -333.29%
Vascular Biogenics Ltd 4 Q 84.19% - -1962.31% 0%
Vaccinex Inc 3 Q - -24560% -8905% 0%
Vera Therapeutics Inc 3 Q - - - -82.41%
Veru Inc 3 Q 47.54% -332.98% -203.23% -354.59%
Verve Therapeutics Inc 3 Q - -1468.01% - -38.83%
Viveon Health Acquisition Corp 4 Q - - - -
Vincerx Pharma Inc 3 Q - - - -160.15%
Virios Therapeutics Inc 4 Q - - - 28.59%
Viracta Therapeutics Inc 3 Q - - - -150.26%
Viking Therapeutics Inc 3 Q - - - -31.28%
Vanda Pharmaceuticals Inc 4 Q 92.36% -5.3% -104.63% 0.46%
Verrica Pharmaceuticals Inc 3 Q - -850.26% - -95.39%
Verona Pharma Plc 4 Q - - - -20.47%
Virpax Pharmaceuticals Inc 3 Q - - - -107.65%
Vertex Pharmaceuticals Inc 4 Q 85.38% 38.48% -29.56% 22.62%
Verastem inc 4 Q - - - -127%
Vistagen Therapeutics Inc 4 Q - -1543.46% - -72.12%
Viatris Inc 4 Q 41.6% -19.95% -8.29% 0.26%
Vtv Therapeutics Inc 4 Q - - - -
Ventyx Biosciences Inc 3 Q - - - -54.28%
Vyne Therapeutics Inc 4 Q - -8142.11% - -79.06%
Wellness Center Usa Inc 2 Q 90.33% -689.92% -20.87% -
Wave Life Sciences Ltd 3 Q - 14.74% -67.09% -
Xenetic Biosciences Inc 3 Q - -172.71% -155.38% -36.09%
Xbiotech Inc 4 Q - - - -10.82%
Exicure Inc 2 Q - - - 34.49%
Xenon Pharmaceuticals Inc 3 Q - - - -25.99%
Xeris Biopharma Holdings Inc 4 Q 82.95% 76.38% 47.54% 12.25%
Xilio Therapeutics inc 3 Q - - - -104.69%
Xencor Inc 4 Q - -43.11% 2.37% -18.7%
Xoma Corporation 4 Q - -1395.58% - -44.17%
Novaccess Global Inc 4 Q - - - -
Xtl Biopharmaceuticals Ltd 4 Q - - - -19.55%
Y mabs Therapeutics inc 3 Q 87.31% -37.88% -6.54% -18.28%
Ys Biopharma Co Ltd 1 Q 77.68% -21.17% 0% -19.97%
Zai Lab Limited 4 Q 61.66% -144.96% 1.01% -37.07%
Zentalis Pharmaceuticals Inc 4 Q - - - -63.95%
Zomedica Corp 3 Q 81.35% -9.16% -114.7% -5.69%
Zosano Pharma Corporation 1 Q 34.85% -25309.85% - -172.07%
Zoetis Inc 4 Q 67.1% 23.63% 12.97% 48.81%
Zevra Therapeutics Inc 3 Q 95.03% -485.15% -791.95% -54.46%
Zyversa Therapeutics Inc 2 Q - - - 0%
Zymeworks Inc 4 Q - -85.56% - -26.2%
Zynerba Pharmaceuticals Inc 2 Q - - - -90.03%
Profitability
Major Pharmaceutical Preparations Industry
Gross margin contracted to 65.69 % in the 4. Quarter 2023 from 68.78 % in previous quarter, now Ranking #25 and ranking within sector #4.
Net margin for Major Pharmaceutical Preparations Industry is 11.96 % above industry average.

More on Major Pharmaceutical Preparations Industry Profitability

Major Pharmaceutical Preparations Industry achieved cash flow margin of 23.52 % and above average return on equity of 8.01 %

More on Major Pharmaceutical Preparations Industry Cash flow
More on Major Pharmaceutical Preparations Industry ROE







Cardiovascular Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Neuroscience Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Anti-Infective Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Respiratory Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Arthritis & Pain Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Urology Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Oncology Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Endocrine Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com